Developmental Funds provide critical support to build research capacity aligned with strategic initiatives. Funds are requested to partially support two key initiatives: 1) recruitment of outstanding investigators to Huntsman Cancer Institute (HCI) ($200,000 per year) and 2) development of our translational research portfolio ($100,000 per year), via the following: Faculty Recruitment: Our five research Programs continue to identify areas of particular opportunity that align with the broad strategic objectives of the Cancer Center. We anticipate that the Cancer Center will spearhead recruitment of approximately 30 new members in the coming five-year period, with particular focus on high-priority areas that have emerged from our strategic planning. These include cancer genetics and epigenetics, cell migration and tumor metastasis, molecular imaging, investigational therapeutics, cancer prevention, epidemiology, behavioral research, and cancer outcomes, including research related to health disparities and survivorship. New recruitment will advance the missions of each of our Programs, with the greatest growth anticipated in our two newest Programs Imaging, Diagnostics, and Therapeutics and Cancer Control and Population Sciences with at least five recruits each. In addition, a major commitment is in place to recruit new leadership for the Divisions of Hematology and Oncology and to expand both Divisions via recruitment of cancer-focused, research-active faculty whose interests align with the abovementioned Cancer Center goals. We plan 14 new cancer-focused faculty recruitments in partnership with these two units during the next five years. These new faculty will be aligned with Cancer Center Programs based on their research interests. We request developmental funds in the amount of $200,000 per year to provide partial support ($50,000 per person) for four newly recruited investigators per year during their initial startup period. Translational Research: We have developed an effective strategy to promote translational research in our Center through the Director's Translational Research Initiative (DTRI). This initiative provides support for promising collaborative projects between basic scientists (including laboratory and population researchers) and clinical investigators. The goal is to stimulate productive transdisciplinary research with near-term clinical application. We request $100,000 per year for the partial support of this mechanism. Total annual support requested from the CCSG for developmental activities is $300,000. This amount will be complemented by HCI discretionary funds and other institutional support.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-23
Application #
8378924
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
23
Fiscal Year
2012
Total Cost
$204,800
Indirect Cost
$22,185
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Tavtigian, Sean V; Greenblatt, Marc S; Harrison, Steven M et al. (2018) Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet Med 20:1054-1060
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Unusual Isothermal Hysteresis in DNA i-Motif pH Transitions: A Study of the RAD17 Promoter Sequence. Biophys J 114:1804-1815
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Rapid Screen of Potential i-Motif Forming Sequences in DNA Repair Gene Promoters. ACS Omega 3:9630-9635
Wei, Xiaomu; Calvo-Vidal, M Nieves; Chen, Siwei et al. (2018) Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma. Cancer Res 78:2747-2759
Sample, Danielle C; Samadder, N Jewel; Pappas, Lisa M et al. (2018) Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol 18:115
Barrott, Jared J; Illum, Benjamin E; Jin, Huifeng et al. (2018) Paracrine osteoprotegerin and ?-catenin stabilization support synovial sarcomagenesis in periosteal cells. J Clin Invest 128:207-218
Madsen, Michael J; Knight, Stacey; Sweeney, Carol et al. (2018) Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15. Cancer Epidemiol Biomarkers Prev 27:644-652
Delker, Don A; Wood, Austin C; Snow, Angela K et al. (2018) Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia. Cancer Prev Res (Phila) 11:4-15
Trott, Daniel W; Henson, Grant D; Ho, Mi H T et al. (2018) Age-related arterial immune cell infiltration in mice is attenuated by caloric restriction or voluntary exercise. Exp Gerontol 109:99-107
Wu, Yelena P; Parsons, Bridget G; Mooney, Ryan et al. (2018) Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children. J Community Health 43:993-1001

Showing the most recent 10 out of 1193 publications